<DOC>
	<DOCNO>NCT01067599</DOCNO>
	<brief_summary>The research project determine level nicotine ST product lead great reduction toxicant exposure</brief_summary>
	<brief_title>Novel Determinants Measures Smokeless Tobacco Use : Study 2</brief_title>
	<detailed_description>This randomize , multi-site trial determine effect switch smokeless tobacco ( ST ) user lower toxicant ST product vary nicotine level biomarkers exposure pattern use . ST user undergo two week baseline assessment period randomly assign one three oral tobacco product ( low NNK plus NNN product three different level nicotine ) period 8-weeks . Follow-up occur 9 20 week .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>1 . Using consistent daily amount ST specific nicotine tobaccospecific nitrosamine ( TSNA ) level past year ; 2 . In good physical health ( unstable medical condition ) ; 3 . Stable , good mental health ( e.g. , recent unstable untreated psychiatric diagnosis , include substance abuse , determine DSMIV criterion ) . 1 . Subjects must currently use tobacco nicotine product . 2 . Female subject pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Biomarkers tobacco exposure</keyword>
	<keyword>Smokeless Tobacco</keyword>
</DOC>